Courtney Hudson
Courtney launched EmergingMed’s navigated clinical trial exchange in 2000
with an unyielding commitment to the belief that anyone with a serious
medical condition should be able to quickly identify and access cutting
edge treatment options typically offered only in clinical trials. With
300,000+ patients served as of January 2015, she established EmergingMed as
a permanent, scalable trustworthy bridge linking patients needing to make
informed treatment decisions with the life sciences industry’s desire to
accelerate the development of new and better treatments. Courtney’s early
career addressed service delivery and health information challenges in the
public sector that proved directly applicable to the establishment of
multiple HMO start-ups in the early 1990s. Immediately prior to founding
EmergingMed, she held rolls in equity research and institutional sales with
CIBC Oppenheimer in New York City. Courtney holds a B.S. in neurobiology
from Yale University and an M.B.A. from the University of Washington in




About me